DDI-MedLine.d203.s0|54-68|antidepressants|group
DDI-MedLine.d203.s0|100-108|residents|drug
DDI-MedLine.d203.s1|3-9|examine|drug
DDI-MedLine.d203.s1|26-34|resident-|drug
DDI-MedLine.d203.s1|129-143|antidepressants|group
DDI-MedLine.d203.s1|154-169|Veterans Affairs|brand
DDI-MedLine.d203.s1|186-198|Living Center|brand
DDI-MedLine.d203.s1|206-214|residents|drug
DDI-MedLine.d203.s3|25-31|VA CLCs|brand
DDI-MedLine.d203.s4|27-36|ninety-two|drug
DDI-MedLine.d203.s4|82-88|January|brand
DDI-MedLine.d203.s4|103-106|June|brand
DDI-MedLine.d203.s5|68-82|antidepressants|group
DDI-MedLine.d203.s5|87-95|residents|drug
DDI-MedLine.d203.s5|153-180|International Classification|brand
DDI-MedLine.d203.s5|185-192|Diseases|brand
DDI-MedLine.d203.s5|195-208|Ninth Revision|brand
DDI-MedLine.d203.s5|211-231|Clinical Modification|brand
DDI-MedLine.d203.s5|254-265|Rating Scale|brand
DDI-MedLine.d203.s6|0-8|Selective|drug
DDI-MedLine.d203.s6|29-38|inhibitors|group
DDI-MedLine.d203.s6|74-87|antidepressant|group
DDI-MedLine.d203.s7|11-19|residents|drug
DDI-MedLine.d203.s7|52-58|receive|drug
DDI-MedLine.d203.s7|63-76|antidepressant|group
DDI-MedLine.d203.s8|3-11|residents|drug
DDI-MedLine.d203.s8|33-56|received antidepressants|group
DDI-MedLine.d203.s9|13-21|residents|drug
DDI-MedLine.d203.s9|94-108|antidepressants|group
DDI-MedLine.d203.s10|30-33|Food|brand
DDI-MedLine.d203.s10|39-66|Drug Administration-approved|brand
DDI-MedLine.d203.s11|23-36|antidepressant|group
DDI-MedLine.d203.s12|20-27|resident|drug
DDI-MedLine.d203.s12|101-113|antipsychotic|group
DDI-MedLine.d203.s12|123-130|evidence|drug
DDI-MedLine.d203.s12|169-176|relative|drug
DDI-MedLine.d203.s12|206-215|confidence|drug
DDI-MedLine.d203.s12|281-292|CI=1.21-1.91|brand
DDI-MedLine.d203.s13|47-58|CI=1.08-2.20|brand
DDI-MedLine.d203.s13|87-96|anxiolytic|drug
DDI-MedLine.d203.s13|101-108|hypnotic|drug
DDI-MedLine.d203.s13|126-137|CI=1.02-1.74|brand
DDI-MedLine.d203.s13|186-199|antidepressant|group
DDI-MedLine.d203.s14|35-49|antidepressants|group
DDI-MedLine.d203.s14|85-87|U.S|brand
DDI-MedLine.d203.s15|8-10|CLC|brand
DDI-MedLine.d203.s15|12-20|residents|drug
DDI-MedLine.d203.s16|29-35|examine|drug
DDI-MedLine.d203.s16|68-81|antidepressant|group
DDI-MedLine.d203.s16|90-92|CLC|brand
DDI-MedLine.d220.s0|14-20|hepatic|drug
DDI-MedLine.d220.s1|4-10|hepatic|drug
DDI-MedLine.d220.s2|34-42|extensive|drug
DDI-MedLine.d220.s4|4-12|predicted|drug
DDI-MedLine.d220.s4|16-20|liver|drug
DDI-MedLine.d220.s4|80-91|respectively|drug
DDI-MedLine.d220.s5|6-28|glucuronidated/sulfated|drug
DDI-MedLine.d220.s5|67-76|determined|drug
DDI-MedLine.d220.s6|131-147|Flos Chrysanthemi|brand
DDI-MedLine.d220.s8|195-200|B-ring|brand
DDI-MedLine.d220.s9|3-8|B-ring|brand
DDI-MedLine.d220.s9|29-31|C-2|brand
DDI-MedLine.d220.s9|49-54|C-ring|brand
DDI-MedLine.d220.s10|7-10|C2-3|brand
DDI-MedLine.d220.s10|48-49|C4|brand
DDI-MedLine.d220.s10|73-78|C-ring|brand
DDI-MedLine.d220.s11|6-14|glycoside|drug
DDI-MedLine.d220.s12|176-186|competitive|drug
DDI-MedLine.d191.s0|51-57|mineral|drug
DDI-MedLine.d191.s0|69-75|Chinese|group
DDI-MedLine.d191.s1|45-51|mineral|drug
DDI-MedLine.d191.s1|63-69|Chinese|group
DDI-MedLine.d191.s2|4-7|S180|brand
DDI-MedLine.d191.s2|127-134|MWCHCP(1|brand
DDI-MedLine.d191.s3|97-106|determined|drug
DDI-MedLine.d191.s4|54-63|protective|drug
DDI-MedLine.d191.s4|75-80|MWCHCP|brand
DDI-MedLine.d191.s5|104-126|factor-alpha (TNF-alpha|group
DDI-MedLine.d191.s5|153-161|intestine|drug
DDI-MedLine.d191.s6|29-34|MWCHCP|brand
DDI-MedLine.d191.s6|219-227|TNF-alpha|group
DDI-MedLine.d191.s6|243-251|intestine|drug
DDI-MedLine.d191.s7|34-39|MWCHCP|brand
DDI-DrugBank.d778.s0|47-56|BILTRICIDE|brand
DDI-DrugBank.d617.s0|99-106|PRIMACOR|brand
DDI-DrugBank.d617.s0|166-175|glycosides|group
DDI-DrugBank.d617.s1|0-8|lidocaine|drug
DDI-DrugBank.d617.s1|11-19|quinidine|drug
DDI-DrugBank.d617.s2|0-10|hydralazine|drug
DDI-DrugBank.d617.s2|13-20|prazosin|drug
DDI-DrugBank.d617.s3|0-9|isosorbide|drug
DDI-DrugBank.d617.s4|16-25|furosemide|drug
DDI-DrugBank.d617.s4|28-46|hydrochlorothiazide|drug
DDI-DrugBank.d617.s4|49-62|spironolactone|drug_n
DDI-DrugBank.d617.s5|0-8|captopril|drug
DDI-DrugBank.d617.s6|0-6|heparin|drug
DDI-DrugBank.d617.s6|9-16|warfarin|drug
DDI-DrugBank.d617.s6|19-26|diazepam|drug
DDI-DrugBank.d617.s8|9-26|Interactions There|brand
DDI-DrugBank.d617.s8|74-82|evidenced|drug
DDI-DrugBank.d617.s8|123-132|furosemide|drug
DDI-DrugBank.d617.s8|166-169|line|drug
DDI-DrugBank.d617.s8|189-196|PRIMACOR|brand
DDI-DrugBank.d617.s9|11-20|furosemide|drug
DDI-DrugBank.d617.s9|64-68|lines|group
DDI-DrugBank.d617.s9|81-88|PRIMACOR|brand
DDI-MedLine.d187.s0|16-26|cannabinoid|drug_n
DDI-MedLine.d187.s1|0-7|Cannabis|drug_n
DDI-MedLine.d187.s2|7-14|cannabis|drug_n
DDI-MedLine.d187.s2|28-33|widely|drug
DDI-MedLine.d187.s3|36-43|cannabis|drug_n
DDI-MedLine.d187.s3|150-157|cannabis|drug_n
DDI-MedLine.d187.s4|2-5|wide|drug
DDI-MedLine.d187.s4|20-34|pharmacokinetic|drug
DDI-MedLine.d187.s5|76-92|phytocannabinoids|drug_n
DDI-MedLine.d187.s5|141-143|THC|brand
DDI-MedLine.d187.s6|58-60|THC|brand
DDI-MedLine.d187.s7|33-44|cannabinoids|drug_n
DDI-MedLine.d187.s7|67-82|pharmacokinetics|group
DDI-MedLine.d187.s7|87-89|THC|brand
DDI-MedLine.d187.s8|14-21|cannabis|drug_n
DDI-MedLine.d187.s9|30-41|cannabinoids|drug_n
DDI-MedLine.d187.s10|25-35|cannabinoid|drug_n
DDI-MedLine.d187.s10|85-97|consideration|drug
DDI-MedLine.d187.s11|35-49|pharmacokinetic|drug
DDI-MedLine.d187.s11|211-220|analytical|drug
DDI-DrugBank.d701.s0|5-16|Interactions|brand
DDI-DrugBank.d701.s0|20-30|Pirenzepine|drug
DDI-DrugBank.d701.s0|102-112|Pirenzepine|drug
DDI-DrugBank.d701.s1|2-9|Antacids|group
DDI-DrugBank.d701.s1|13-20|Diarrhea|brand
DDI-DrugBank.d701.s1|22-29|medicine|drug
DDI-DrugBank.d701.s1|66-77|Ketoconazole|drug
DDI-DrugBank.d701.s1|81-87|Central|brand
DDI-DrugBank.d701.s1|124-145|Other anticholinergics|group
DDI-DrugBank.d701.s1|149-173|Tricyclic antidepressants|group
DDI-DrugBank.d701.s1|182-187|Elavil|brand
DDI-DrugBank.d701.s1|190-196|Asendin|brand
DDI-DrugBank.d701.s1|199-207|Anafranil|brand
DDI-DrugBank.d701.s1|210-219|Pertofrane|brand
DDI-DrugBank.d701.s1|222-229|Sinequan|drug
DDI-DrugBank.d701.s1|232-239|Tofranil|brand
DDI-DrugBank.d701.s1|242-248|Aventyl|brand
DDI-DrugBank.d701.s1|251-259|Surmontil|brand
DDI-DrugBank.d701.s1|264-272|Potassium|brand
DDI-DrugBank.d701.s1|274-281|chloride|drug
DDI-DrugBank.d701.s1|290-297|Kay Ciel|brand
DDI-MedLine.d183.s0|38-41|MPTP|drug_n
DDI-MedLine.d183.s0|71-97|tetrahydropyridine)-induced|drug
DDI-MedLine.d183.s0|114-124|Parkinson's|brand
DDI-MedLine.d183.s1|37-53|neurodegenerative|drug
DDI-MedLine.d183.s2|37-65|progressive neurodegenerative|drug
DDI-MedLine.d183.s2|89-97|selective|drug
DDI-MedLine.d183.s2|115-126|dopaminergic|drug
DDI-MedLine.d183.s2|143-152|substantia|group
DDI-MedLine.d183.s3|30-31|PD|brand
DDI-MedLine.d183.s3|49-60|bradykinesia|group
DDI-MedLine.d183.s4|35-36|PD|brand
DDI-MedLine.d183.s4|99-100|PD|brand
DDI-MedLine.d183.s4|132-142|neurotoxins|group
DDI-MedLine.d183.s5|85-108|tetrahydropyridine (MPTP|drug_n
DDI-MedLine.d183.s5|175-176|PD|brand
DDI-MedLine.d183.s6|56-59|MPTP|drug_n
DDI-MedLine.d183.s6|88-95|tyrosine|drug
DDI-MedLine.d183.s6|113-120|dopamine|drug
DDI-MedLine.d183.s6|153-160|dopamine|drug
DDI-MedLine.d183.s6|222-225|MPTP|drug_n
DDI-MedLine.d183.s7|54-57|MPTP|drug_n
DDI-MedLine.d183.s7|97-113|neurodegenerative|drug
DDI-MedLine.d183.s7|128-129|PD|brand
DDI-MedLine.d183.s8|31-45|neuroprotective|drug
DDI-MedLine.d183.s8|109-112|MPTP|drug_n
DDI-MedLine.d183.s8|123-124|PD|brand
DDI-MedLine.d183.s9|55-56|PD|brand
DDI-MedLine.d183.s9|69-75|provide|drug
DDI-MedLine.d183.s9|108-118|therapeutic|drug
DDI-MedLine.d183.s9|137-138|PD|brand
DDI-DrugBank.d586.s0|31-36|Elidel|drug
DDI-DrugBank.d586.s0|94-107|systematically|drug
DDI-DrugBank.d586.s1|102-109|systemic|group
DDI-DrugBank.d586.s2|56-65|inhibitors|group
DDI-DrugBank.d586.s2|84-93|widespread|group
DDI-DrugBank.d586.s3|32-43|erythromycin|drug
DDI-DrugBank.d586.s3|46-57|itraconazole|drug
DDI-DrugBank.d586.s3|60-71|ketoconazole|drug
DDI-DrugBank.d586.s3|74-84|fluconazole|drug
DDI-DrugBank.d586.s3|95-101|channel|drug_n
DDI-DrugBank.d586.s3|116-125|cimetidine|drug
DDI-MedLine.d198.s0|73-79|channel|drug_n
DDI-MedLine.d198.s2|58-61|GLIC|brand
DDI-MedLine.d198.s2|66-76|prokaryotic|drug
DDI-MedLine.d198.s2|120-126|channel|drug_n
DDI-MedLine.d198.s2|144-151|provides|group
DDI-MedLine.d198.s2|235-242|channels|drug_n
DDI-MedLine.d198.s3|17-20|GLIC|brand
DDI-MedLine.d198.s3|86-95|eukaryotic|drug
DDI-MedLine.d198.s3|174-177|GLIC|brand
DDI-MedLine.d198.s4|80-86|glycine|drug
DDI-MedLine.d198.s4|115-127|acetylcholine|drug
DDI-MedLine.d198.s4|134-137|GLIC|brand
DDI-MedLine.d198.s5|43-44|M2|brand
DDI-MedLine.d198.s6|57-60|side|drug
DDI-MedLine.d198.s6|85-88|GLIC|brand
DDI-MedLine.d198.s6|104-128|ethanol-sensitive channel|drug_n
DDI-MedLine.d198.s6|149-158|eukaryotic|drug
DDI-MedLine.d198.s6|160-168|relatives|group
DDI-MedLine.d198.s7|21-22|M2|brand
DDI-MedLine.d198.s8|31-40|elucidated|drug
DDI-MedLine.d198.s8|244-251|tunnel."|drug_n
DDI-MedLine.d198.s9|14-20|provide|drug
DDI-DrugBank.d574.s0|5-12|medicine|drug
DDI-DrugBank.d574.s0|133-154|thinner (anticoagulant|group
DDI-DrugBank.d574.s0|158-168|cyclosporin|drug
DDI-MedLine.d206.s0|14-27|antidepressant|group
DDI-MedLine.d206.s0|80-89|fluoxetine|drug
DDI-MedLine.d206.s0|95-104|imipramine|drug
DDI-MedLine.d206.s1|16-21|active|drug
DDI-MedLine.d206.s1|57-62|Curuma|brand
DDI-MedLine.d206.s1|70-73|Linn|drug_n
DDI-MedLine.d206.s2|26-39|antidepressant|group
DDI-MedLine.d206.s2|92-101|fluoxetine|drug
DDI-MedLine.d206.s2|107-116|imipramine|drug
DDI-MedLine.d206.s2|306-308|FST|brand
DDI-MedLine.d206.s3|96-100|given|drug
DDI-MedLine.d206.s3|127-131|Group|brand
DDI-MedLine.d206.s3|213-223|(fluoxetine|drug
DDI-MedLine.d206.s3|244-254|(imipramine|drug
DDI-MedLine.d206.s3|300-309|fluoxetine|drug
DDI-MedLine.d206.s3|358-367|imipramine|drug
DDI-MedLine.d206.s5|24-26|FST|brand
DDI-MedLine.d206.s5|32-34|TST|brand
DDI-MedLine.d206.s5|62-64|FST|brand
DDI-MedLine.d206.s5|102-115|antidepressant|group
DDI-MedLine.d206.s6|58-67|fluoxetine|drug
DDI-MedLine.d206.s6|73-82|imipramine|drug
DDI-MedLine.d206.s6|115-124|fluoxetine|drug
DDI-MedLine.d206.s6|130-139|imipramine|drug
DDI-MedLine.d206.s6|163-176|antidepressant|group
DDI-MedLine.d206.s7|62-64|FST|brand
DDI-MedLine.d206.s7|76-89|antidepressant|group
DDI-MedLine.d206.s7|147-160|norepinephrine|drug
DDI-MedLine.d206.s7|166-173|dopamine|drug
DDI-MedLine.d206.s8|25-38|antidepressant|group
DDI-MedLine.d206.s8|121-134|catecholamines|group
DDI-DrugBank.d667.s0|56-60|given|drug
DDI-DrugBank.d667.s0|92-103|prophylactic|drug
DDI-DrugBank.d667.s2|128-139|cyclopropane|drug
DDI-MedLine.d215.s0|9-21|antimicrobial|group
DDI-MedLine.d215.s0|36-59|synergistic/antagonistic|drug
DDI-MedLine.d215.s0|92-102|antibiotics|group
DDI-MedLine.d215.s2|60-72|antimicrobial|group
DDI-MedLine.d215.s2|124-145|Rosmarinus officinalis|drug
DDI-MedLine.d215.s2|159-168|Coriandrum|brand
DDI-MedLine.d215.s2|191-200|Micromeria|brand
DDI-MedLine.d215.s2|202-210|fruticosa|drug
DDI-MedLine.d215.s4|12-14|P.H|brand
DDI-MedLine.d215.s5|26-31|Cumium|brand
DDI-MedLine.d215.s5|50-55|Mentha|brand
DDI-MedLine.d215.s5|197-207|antibiotics|group
DDI-MedLine.d215.s6|29-39|Micrococcus|brand
DDI-MedLine.d215.s6|48-49|LA|brand
DDI-MedLine.d215.s6|57-64|Bacillus|brand
DDI-MedLine.d215.s6|77-79|NRS|brand
DDI-MedLine.d215.s6|82-89|Bacillus|brand
DDI-MedLine.d215.s6|98-100|FMC|brand
DDI-MedLine.d215.s6|105-116|Enterococcus|brand
DDI-MedLine.d215.s6|127-130|ATCC|brand
DDI-MedLine.d215.s6|139-149|Pseudomonas|brand
DDI-MedLine.d215.s6|162-163|DC|brand
DDI-MedLine.d215.s6|170-182|Mycobacterium|brand
DDI-MedLine.d215.s6|194-196|CCM|brand
DDI-MedLine.d215.s6|204-214|Escherichia|brand
DDI-MedLine.d215.s6|221-222|DM|brand
DDI-MedLine.d215.s6|225-233|Aeromonas|brand
DDI-MedLine.d215.s6|246-249|ATCC|brand
DDI-MedLine.d215.s6|257-264|Yersinia|brand
DDI-MedLine.d215.s6|266-279|enterocolitica|drug
DDI-MedLine.d215.s6|281-282|AU|brand
DDI-MedLine.d215.s6|288-301|Staphylococcus|brand
DDI-MedLine.d215.s6|310-314|Cowan|brand
DDI-MedLine.d215.s6|319-331|Streptococcus|brand
DDI-MedLine.d215.s6|342-343|DC|brand
DDI-MedLine.d215.s6|362-374|Saccharomyces|brand
DDI-MedLine.d215.s6|387-389|WET|brand
DDI-MedLine.d215.s6|396-408|Kluvyeromyces|brand
DDI-MedLine.d215.s6|419-420|DC|brand
DDI-MedLine.d215.s7|45-66|Rosmarinus officinalis|drug
DDI-MedLine.d215.s7|69-78|Coriandrum|brand
DDI-MedLine.d215.s7|88-89|L.|brand
DDI-MedLine.d215.s7|92-101|Micromeria|brand
DDI-MedLine.d215.s7|103-111|fruticosa|drug
DDI-MedLine.d215.s9|12-14|P.H|brand
DDI-MedLine.d215.s10|7-12|Cumium|brand
DDI-MedLine.d215.s10|22-23|L.|brand
DDI-MedLine.d215.s10|26-31|Mentha|brand
DDI-MedLine.d215.s11|11-23|antimicrobial|group
DDI-MedLine.d215.s12|9-18|antibiotic|group
DDI-MedLine.d215.s12|28-37|Gentamicin|drug
DDI-MedLine.d215.s12|52-62|Cephalothin|brand
DDI-MedLine.d215.s12|77-87|Ceftriaxone|brand
DDI-MedLine.d215.s12|102-109|Nystatin|drug
DDI-MedLine.d215.s12|115-115|U|brand
DDI-MedLine.d215.s12|158-170|antimicrobial|group
DDI-MedLine.d215.s13|13-25|antibacterial|group
DDI-MedLine.d215.s13|142-152|antibiotics|group
DDI-MedLine.d215.s14|9-21|antibacterial|group
DDI-MedLine.d215.s14|93-103|antibiotics|group
DDI-MedLine.d215.s15|10-17|additive|drug
DDI-MedLine.d215.s15|58-70|antibacterial|group
DDI-DrugBank.d662.s0|58-62|urine|drug
DDI-DrugBank.d662.s0|220-232|enterohepatic|drug
DDI-DrugBank.d662.s1|107-114|received|drug
DDI-DrugBank.d662.s1|116-125|NOVANTRONE|brand
DDI-DrugBank.d662.s3|39-48|NOVANTRONE|brand
DDI-DrugBank.d662.s3|58-72|corticosteroids|drug
DDI-DrugBank.d662.s3|78-85|evidence|drug
DDI-DrugBank.d594.s0|18-34|cylcopholsphamide|drug
DDI-DrugBank.d594.s0|37-47|fludarabine|drug
DDI-DrugBank.d594.s0|53-62|vidarabine|drug
DDI-MedLine.d142.s0|35-50|pharmacokinetics|group
DDI-MedLine.d142.s1|56-71|pharmacokinetics|group
DDI-MedLine.d142.s1|73-86|characteristic|drug
DDI-MedLine.d142.s2|9-16|received|drug
DDI-MedLine.d142.s2|113-124|respectively|drug
DDI-MedLine.d142.s3|52-56|LC-MS|brand
DDI-MedLine.d142.s4|34-41|DAS2.1.1|brand
DDI-MedLine.d142.s5|52-53|Ke|brand
DDI-MedLine.d142.s5|89-90|Ka|brand
DDI-MedLine.d142.s5|96-109|AUC(0-infinity|brand
DDI-DrugBank.d674.s0|32-43|phentolamine|drug
DDI-DrugBank.d674.s1|73-81|sustained|drug
DDI-DrugBank.d674.s2|0-13|False-positive|drug
DDI-MedLine.d144.s3|26-29|PHAs|brand
DDI-MedLine.d144.s3|106-114|practices|drug
DDI-DrugBank.d714.s0|20-22|CNS|brand
DDI-DrugBank.d714.s0|39-63|trycyclic antidepressants|group
DDI-MedLine.d182.s0|0-12|Antimicrobial|group
DDI-MedLine.d182.s2|29-41|antimicrobial|group
DDI-MedLine.d182.s3|83-94|bactericidal|drug
DDI-MedLine.d182.s3|121-130|determined|drug
DDI-MedLine.d182.s3|140-152|Streptococcus|brand
DDI-MedLine.d182.s3|162-172|Actinomyces|brand
DDI-MedLine.d182.s3|184-196|Porphyromonas|brand
DDI-MedLine.d182.s3|210-222|Fusobacterium|brand
DDI-MedLine.d182.s3|238-244|Candida|brand
DDI-MedLine.d182.s4|41-47|MIC/MBC|brand
DDI-MedLine.d182.s11|13-15|MIC|brand
DDI-MedLine.d182.s13|15-17|MIC|brand
DDI-MedLine.d182.s15|8-13|agents|group
DDI-MedLine.d182.s17|16-18|MIC|brand
DDI-MedLine.d182.s17|72-83|respectively|drug
DDI-MedLine.d182.s19|33-38|agents|group
DDI-MedLine.d182.s19|44-51|additive|drug
DDI-MedLine.d182.s20|18-25|chloride|drug
DDI-MedLine.d182.s20|121-132|respectively|drug
DDI-MedLine.d182.s21|40-52|antimicrobial|group
DDI-MedLine.d182.s22|0-10|Synergistic|drug
DDI-MedLine.d221.s1|33-40|etizolam|drug
DDI-MedLine.d221.s1|43-55|phenobarbital|drug
DDI-MedLine.d221.s1|58-69|promethazine|drug
DDI-MedLine.d221.s1|75-88|chlorpromazine|drug
DDI-MedLine.d221.s2|0-11|Quantitative|group
DDI-MedLine.d221.s2|70-77|etizolam|drug
DDI-MedLine.d221.s2|80-92|phenobarbital|drug
DDI-MedLine.d221.s2|95-106|promethazine|drug
DDI-MedLine.d221.s2|112-125|chlorpromazine|drug
DDI-MedLine.d221.s2|216-227|respectively|drug
DDI-MedLine.d197.s0|0-7|[Vitamin|drug
DDI-MedLine.d197.s1|31-39|vitamin D|group
DDI-MedLine.d197.s1|46-53|received|drug
DDI-MedLine.d197.s1|102-115|pharmaceutical|drug
DDI-MedLine.d197.s3|73-76|side|drug
DDI-MedLine.d197.s4|41-49|vitamin D|group
DDI-MedLine.d197.s5|82-86|CYP24|brand
DDI-MedLine.d197.s5|141-149|vitamin D|group
DDI-MedLine.d197.s6|22-25|wide|drug
DDI-MedLine.d197.s6|38-58|pharmaceutical agents|group
DDI-MedLine.d197.s6|69-81|antiepileptic|group
DDI-MedLine.d197.s6|97-106|rifampicin|drug
DDI-MedLine.d197.s6|136-140|virus|drug
DDI-MedLine.d197.s6|151-160|inhibitors|group
DDI-MedLine.d197.s6|170-178|ritonavir|drug
DDI-MedLine.d197.s6|184-193|saquinavir|drug
DDI-MedLine.d197.s7|0-5|Beside|drug
DDI-MedLine.d197.s7|56-64|vitamin D|group
DDI-MedLine.d197.s7|151-157|statins|group
DDI-MedLine.d197.s7|163-172|cytostatic|drug
DDI-DrugBank.d760.s0|12-27|Therapy Special|brand
DDI-DrugBank.d760.s0|134-145|systemically|group
DDI-DrugBank.d760.s0|176-181|agents|group
DDI-DrugBank.d760.s0|223-233|derivatives|group
DDI-DrugBank.d760.s0|250-263|phenothiazines|group
DDI-DrugBank.d760.s0|294-308|salicylanilides|group
DDI-DrugBank.d760.s0|310-324|(bacteriostatic|drug
DDI-DrugBank.d760.s0|334-345|sulfonamides|group
DDI-DrugBank.d760.s0|348-360|tetracyclines|group
DDI-DrugBank.d760.s0|363-371|thiazides|group
DDI-DrugBank.d760.s0|432-440|toluidine|drug
DDI-DrugBank.d708.s0|65-72|Vectibix|brand
DDI-MedLine.d226.s2|7-9|QCs|brand
DDI-MedLine.d226.s2|55-63|practices|drug
DDI-MedLine.d226.s3|4-6|QCs|brand
DDI-MedLine.d226.s4|4-5|QC|brand
DDI-MedLine.d226.s6|31-36|guided|drug
DDI-MedLine.d226.s6|43-49|trained|drug
DDI-MedLine.d226.s7|261-262|QC|brand
DDI-MedLine.d226.s11|38-39|QC|brand
DDI-MedLine.d226.s11|85-89|T-QCs|brand
DDI-MedLine.d226.s12|37-56|critical perspective|drug
DDI-MedLine.d167.s1|28-34|evident|drug
DDI-MedLine.d167.s1|121-127|diverse|drug
DDI-MedLine.d167.s1|177-182|agents|group
DDI-MedLine.d167.s2|36-42|provide|drug
DDI-MedLine.d167.s2|62-70|effective|drug
DDI-MedLine.d167.s4|71-79|practices|drug
DDI-MedLine.d167.s4|163-171|perceived|drug
DDI-MedLine.d150.s0|53-63|side-effect|drug
DDI-MedLine.d150.s1|36-43|identify|drug
DDI-MedLine.d150.s1|116-119|side|drug
DDI-MedLine.d150.s2|14-17|side|drug
DDI-MedLine.d150.s3|9-19|side-effect|drug
DDI-MedLine.d150.s4|49-59|side-effect|drug
DDI-MedLine.d150.s5|39-49|side-effect|drug
DDI-MedLine.d150.s5|145-155|side-effect|drug
DDI-MedLine.d150.s6|43-46|side|drug
DDI-MedLine.d150.s6|76-81|linear|drug
DDI-MedLine.d150.s7|26-31|gained|drug
DDI-MedLine.d150.s7|80-83|side|drug
DDI-MedLine.d150.s8|120-123|side|drug
DDI-DrugBank.d749.s0|54-60|Macugen|brand
DDI-DrugBank.d749.s2|53-60|received|drug
DDI-DrugBank.d749.s2|62-68|Macugen|brand
DDI-DrugBank.d749.s2|100-102|PDT|brand
DDI-DrugBank.d749.s2|150-165|pharmacokinetics|group
DDI-MedLine.d223.s1|5-11|article|drug
DDI-MedLine.d223.s2|86-101|pharmacokinetics|group
DDI-MedLine.d223.s4|62-71|considered|drug
DDI-DrugBank.d740.s0|16-31|Test Interaction|brand
DDI-DrugBank.d740.s0|34-36|The|brand
DDI-DrugBank.d740.s0|57-78|anticholinergic agents|group
DDI-DrugBank.d740.s0|98-111|hyporesponsive|drug
DDI-DrugBank.d740.s1|20-27|positive|drug
DDI-DrugBank.d626.s0|54-63|primaquine|drug
DDI-MedLine.d160.s0|77-83|Chinese|group
DDI-MedLine.d160.s0|85-96|Pharmacopeia|brand
DDI-MedLine.d160.s1|55-68|pharmaceutical|drug
DDI-MedLine.d160.s1|115-127|effectiveness|drug
DDI-MedLine.d160.s2|45-58|pharmaceutical|drug
DDI-MedLine.d229.s0|24-34|synergistic|drug
DDI-MedLine.d229.s0|51-60|Bortezomib|brand
DDI-MedLine.d229.s0|66-70|TRAIL|brand
DDI-MedLine.d229.s0|78-85|provides|group
DDI-MedLine.d229.s1|25-34|Bortezomib|brand
DDI-MedLine.d229.s1|45-54|identified|drug
DDI-MedLine.d229.s1|80-92|TRAIL-induced|brand
DDI-MedLine.d229.s2|75-85|synergistic|drug
DDI-MedLine.d229.s3|15-24|identifies|drug
DDI-MedLine.d229.s3|73-77|TRAIL|brand
DDI-MedLine.d229.s3|83-92|Bortezomib|brand
DDI-MedLine.d145.s0|46-56|doxorubicin|drug
DDI-MedLine.d145.s0|102-106|lines|group
DDI-MedLine.d145.s2|79-83|IGF1R|brand
DDI-MedLine.d145.s2|110-115|AG1024|brand
DDI-MedLine.d145.s2|147-157|doxorubicin|drug
DDI-MedLine.d145.s2|195-199|lines|group
DDI-MedLine.d145.s2|224-244|doxorubicin-resistant|drug
DDI-MedLine.d145.s2|251-254|line|drug
DDI-MedLine.d145.s3|44-48|IGF1R|brand
DDI-MedLine.d145.s3|64-74|doxorubicin|drug
DDI-MedLine.d145.s3|85-110|additive anti-osteosarcoma|group
DDI-MedLine.d145.s3|193-197|cycle|drug
DDI-MedLine.d145.s4|15-19|IGF1R|brand
DDI-MedLine.d145.s4|44-54|doxorubicin|drug
DDI-MedLine.d145.s4|95-99|lines|group
DDI-MedLine.d146.s0|30-33|H1N1|brand
DDI-MedLine.d146.s0|40-50|oseltamivir|drug
DDI-MedLine.d146.s0|91-99|effective|drug
DDI-MedLine.d146.s0|113-128|immunosuppresive|drug
DDI-MedLine.d146.s1|52-55|H1N1|brand
DDI-MedLine.d146.s2|84-92|antiviral|group
DDI-MedLine.d146.s2|108-115|critical|drug
DDI-MedLine.d146.s3|29-32|H1N1|brand
DDI-MedLine.d146.s3|39-49|oseltamivir|drug
DDI-MedLine.d146.s3|61-69|effective|drug
DDI-MedLine.d146.s3|101-104|H1N1|brand
DDI-MedLine.d146.s3|118-122|virus|drug
DDI-MedLine.d146.s4|0-10|Oseltamivir|drug
DDI-MedLine.d146.s4|16-24|effective|drug
DDI-MedLine.d146.s4|59-62|H1N1|brand
DDI-MedLine.d210.s0|22-35|P-glycoprotein|brand
DDI-MedLine.d210.s1|31-44|P-glycoprotein|brand
DDI-MedLine.d210.s1|85-91|article|drug
DDI-MedLine.d210.s2|33-38|widely|drug
DDI-MedLine.d210.s2|72-85|P-glycoprotein|brand
DDI-MedLine.d210.s3|79-92|P-glycoprotein|brand
DDI-MedLine.d210.s4|133-146|P-glycoprotein|brand
DDI-MedLine.d173.s1|87-94|HIV/AIDS|brand
DDI-MedLine.d173.s1|157-171|HIV-co-infected|brand
DDI-MedLine.d173.s2|28-29|TB|brand
DDI-MedLine.d173.s2|67-71|given|drug
DDI-MedLine.d173.s3|76-86|alternative|drug
DDI-MedLine.d173.s4|4-19|antituberculosis|group
DDI-MedLine.d173.s4|143-144|TB|brand
DDI-DrugBank.d681.s0|18-27|cimetidine|drug
DDI-DrugBank.d681.s0|30-36|digoxin|drug
DDI-DrugBank.d681.s0|39-47|medicines|group
DDI-DrugBank.d681.s0|89-100|theophylline|drug
DDI-DrugBank.d705.s0|0-10|Telbivudine|drug
DDI-DrugBank.d705.s0|34-40|passive|drug
DDI-DrugBank.d705.s0|94-104|telbivudine|drug
DDI-DrugBank.d705.s1|17-27|telbivudine|drug
DDI-DrugBank.d705.s1|96-106|telbivudine|drug
DDI-DrugBank.d705.s1|180-190|telbivudine|drug
DDI-DrugBank.d589.s0|12-25|glucocorticoid|drug
DDI-DrugBank.d589.s0|63-67|Geref|brand
DDI-DrugBank.d589.s0|73-77|There|brand
DDI-DrugBank.d589.s0|86-93|evidence|drug
DDI-DrugBank.d589.s0|124-128|Geref|brand
DDI-DrugBank.d589.s0|192-198|routine|drug
DDI-MedLine.d148.s0|88-94|Rev-erb|brand
DDI-MedLine.d148.s0|100-113|Oligophrenin-1|brand
DDI-MedLine.d148.s0|125-139|dendritic spine|drug
DDI-MedLine.d148.s2|62-68|Rev-erb|brand
DDI-MedLine.d148.s3|44-50|Rev-erb|brand
DDI-MedLine.d148.s4|105-109|Bmal1|brand
DDI-MedLine.d148.s4|126-130|Arntl|brand
DDI-MedLine.d148.s4|155-161|Rev-erb|brand
DDI-MedLine.d148.s5|19-26|synaptic|drug
DDI-MedLine.d148.s5|45-51|Rev-erb|brand
DDI-MedLine.d148.s5|85-90|spines|group
DDI-MedLine.d148.s5|123-126|AMPA|brand
DDI-MedLine.d148.s6|41-48|synaptic|drug
DDI-MedLine.d148.s6|90-98|delineate|drug
DDI-MedLine.d148.s6|166-172|provide|drug
DDI-MedLine.d148.s6|194-203|plasticity|drug
DDI-DrugBank.d685.s1|156-170|anticoagulation|group
DDI-DrugBank.d685.s2|21-47|Interactions Administration|brand
DDI-DrugBank.d685.s2|56-61|BEXXAR|brand
DDI-DrugBank.d685.s2|63-73|therapeutic|drug
DDI-DrugBank.d685.s2|122-143|anti-murine antibodies|group
DDI-DrugBank.d685.s3|16-19|HAMA|brand
DDI-DrugBank.d685.s3|84-93|diagnostic|drug
DDI-DrugBank.d685.s3|153-170|therapeutic agents|group
DDI-DrugBank.d685.s3|185-199|murine antibody|group
DDI-DrugBank.d685.s4|17-20|HAMA|brand
DDI-DrugBank.d685.s4|22-29|positive|drug
DDI-DrugBank.d685.s4|97-100|side|drug
DDI-DrugBank.d685.s4|134-143|diagnostic|drug
DDI-DrugBank.d685.s4|171-176|murine|drug
DDI-DrugBank.d685.s4|189-198|antibodies|group
DDI-MedLine.d171.s0|40-46|viruses|drug
DDI-MedLine.d171.s0|49-55|Part II|brand
DDI-MedLine.d171.s0|58-71|Antiretroviral|group
DDI-MedLine.d171.s0|80-90|therapeutic|drug
DDI-MedLine.d171.s0|105-116|diagnostics]|group
DDI-MedLine.d171.s1|43-47|virus|drug
DDI-MedLine.d171.s1|151-154|wide|drug
DDI-MedLine.d171.s1|172-184|opportunistic|drug
DDI-MedLine.d171.s2|37-57|active antiretroviral|group
DDI-MedLine.d171.s2|97-99|HIV|brand
DDI-MedLine.d171.s2|151-163|AIDS-defining|brand
DDI-MedLine.d171.s3|19-34|antiretrovirally|group
DDI-MedLine.d171.s3|44-55|HIV-infected|brand
DDI-MedLine.d171.s3|73-77|HAART|brand
DDI-MedLine.d171.s3|88-99|considerably|drug
DDI-MedLine.d171.s4|29-33|HIV-1|brand
DDI-MedLine.d171.s4|71-91|antiretroviral agents|group
DDI-MedLine.d171.s5|38-47|nucleoside|drug
DDI-MedLine.d171.s5|52-61|nucleotide|drug
DDI-MedLine.d171.s5|85-94|inhibitors|group
DDI-MedLine.d171.s5|119-132|non-nucleoside|drug
DDI-MedLine.d171.s5|166-171|(NNRTI|drug_n
DDI-MedLine.d171.s6|18-31|antiretroviral|group
DDI-MedLine.d171.s6|44-57|antiretroviral|group
DDI-MedLine.d171.s6|208-217|considered|drug
DDI-MedLine.d171.s7|0-10|Diagnostics|group
DDI-MedLine.d171.s7|15-17|HIV|brand
DDI-MedLine.d171.s7|65-74|antibodies|group
DDI-MedLine.d224.s0|66-83|carbamide peroxide|drug
DDI-MedLine.d224.s1|108-113|agents|group
DDI-MedLine.d224.s1|171-194|carbamide peroxide-based|drug
DDI-MedLine.d224.s2|6-11|bovine|drug
DDI-MedLine.d224.s2|97-103|divided|drug
DDI-MedLine.d224.s3|51-74|carbamide peroxide-based|drug
DDI-MedLine.d224.s4|25-48|carbamide peroxide-based|drug
DDI-MedLine.d224.s5|45-58|Vita Easyshade|brand
DDI-MedLine.d224.s6|42-46|E*Lab|brand
DDI-MedLine.d224.s7|27-37|statistical|drug
DDI-MedLine.d224.s8|19-20|SD|brand
DDI-MedLine.d224.s10|40-57|carbamide peroxide|drug
DDI-DrugBank.d592.s0|24-41|Tetradecyl Sulfate|brand
DDI-DrugBank.d592.s0|45-46|No|brand
DDI-DrugBank.d592.s0|111-130|antiovulatory agents|group
DDI-DrugBank.d592.s1|64-76|antiovulatory|group
DDI-DrugBank.d592.s1|119-128|Sotradecol|brand
DDI-DrugBank.d592.s2|0-6|Heparin|drug
DDI-DrugBank.d592.s2|61-78|Tetradecyl Sulfate|brand
DDI-DrugBank.d768.s0|0-11|Palonosetron|drug
DDI-DrugBank.d768.s0|131-133|CYP|brand
DDI-DrugBank.d768.s1|32-43|palonosetron|drug
DDI-DrugBank.d768.s1|68-73|CYP1A2|brand
DDI-DrugBank.d768.s1|76-81|CYP2A6|brand
DDI-DrugBank.d768.s1|84-89|CYP2B6|brand
DDI-DrugBank.d768.s1|92-97|CYP2C9|drug
DDI-DrugBank.d768.s1|100-105|CYP2D6|drug
DDI-DrugBank.d768.s1|108-113|CYP2E1|brand
DDI-DrugBank.d768.s1|194-199|CYP1A2|brand
DDI-DrugBank.d768.s1|202-207|CYP2D6|drug
DDI-DrugBank.d768.s2|75-86|palonosetron|drug
DDI-DrugBank.d768.s3|52-53|IV|brand
DDI-DrugBank.d768.s3|55-66|palonosetron|drug
DDI-DrugBank.d768.s3|100-113|metoclopramide|drug
DDI-DrugBank.d768.s3|168-182|pharmacokinetic|drug
DDI-DrugBank.d768.s4|31-35|ALOXI|brand
DDI-DrugBank.d768.s4|81-95|corticosteroids|drug
DDI-DrugBank.d768.s4|110-134|antiemetics/antinauseants|group
DDI-DrugBank.d768.s4|137-150|antispasmodics|group
DDI-DrugBank.d768.s4|156-177|anticholinergic agents|group
DDI-DrugBank.d768.s5|0-11|Palonosetron|drug
DDI-DrugBank.d768.s5|33-41|antitumor|group
DDI-DrugBank.d768.s5|64-86|chemotherapeutic agents|group
DDI-DrugBank.d768.s5|107-122|cyclophosphamide|drug
DDI-DrugBank.d768.s5|125-134|cytarabine|drug
DDI-DrugBank.d768.s5|137-147|doxorubicin|drug
DDI-DrugBank.d768.s5|153-161|mitomycin|drug
DDI-DrugBank.d768.s5|163-163|C|brand
DDI-DrugBank.d768.s5|169-174|murine|drug
DDI-MedLine.d157.s0|24-33|evidential|drug
DDI-MedLine.d157.s1|11-18|examines|group
DDI-MedLine.d157.s1|63-73|methysticum|drug
DDI-MedLine.d157.s1|75-79|Forst|brand
DDI-MedLine.d157.s1|85-94|Piperaceae|brand
DDI-MedLine.d157.s1|106-111|native|drug
DDI-MedLine.d157.s1|116-122|Oceania|brand
DDI-MedLine.d157.s2|26-37|anti-anxiety|group
DDI-MedLine.d157.s2|52-58|Western|brand
DDI-MedLine.d157.s2|113-118|banned|drug_n
DDI-MedLine.d157.s2|161-165|liver|drug
DDI-MedLine.d157.s3|107-116|evidential|drug
DDI-MedLine.d157.s5|137-145|narrative|drug
DDI-MedLine.d157.s6|70-78|political|drug
DDI-MedLine.d222.s0|13-20|nicotine|drug
DDI-MedLine.d222.s0|38-44|Chantix|group
DDI-MedLine.d222.s0|46-57|(varenicline|drug
DDI-MedLine.d222.s1|0-10|Varenicline|drug
DDI-MedLine.d222.s1|36-42|Chantix|group
DDI-MedLine.d222.s2|47-56|abstinence|drug
DDI-MedLine.d222.s2|92-101|varencline|drug
DDI-MedLine.d222.s2|165-166|SR|brand
DDI-MedLine.d222.s3|0-10|Varenicline|drug
DDI-MedLine.d222.s3|20-27|nicotine|drug
DDI-MedLine.d222.s3|72-79|nicotine|drug
DDI-MedLine.d222.s4|101-111|varenicline|drug
DDI-MedLine.d222.s6|145-155|varenicline|drug
DDI-DrugBank.d612.s0|58-69|pioglitazone|drug
DDI-DrugBank.d612.s0|96-98|CYP|brand
DDI-MedLine.d156.s0|42-47|Brugia|brand
DDI-MedLine.d156.s0|59-68|moxidectin|drug
DDI-MedLine.d156.s1|5-7|ABC|brand
DDI-MedLine.d156.s3|23-25|ABC|brand
DDI-MedLine.d156.s3|78-80|MDR|brand
DDI-MedLine.d156.s4|88-97|ivermectin|drug
DDI-MedLine.d156.s5|4-9|Brugia|brand
DDI-MedLine.d156.s5|18-20|ABC|brand
DDI-MedLine.d156.s5|50-57|examined|drug
DDI-MedLine.d156.s5|113-122|moxidectin|drug
DDI-MedLine.d156.s6|39-41|ABC|brand
DDI-MedLine.d156.s7|21-30|moxidectin|drug
DDI-MedLine.d156.s7|37-46|inhibitors|group
DDI-MedLine.d156.s7|51-53|ABC|brand
DDI-MedLine.d156.s7|107-116|moxidectin|drug
DDI-MedLine.d156.s9|23-25|ABC|brand
DDI-MedLine.d156.s9|65-74|moxidectin|drug
DDI-MedLine.d153.s0|17-41|propiverine hydrochloride|drug
DDI-MedLine.d153.s0|146-160|pharmacokinetic|drug
DDI-MedLine.d153.s0|173-181|sustained|drug
DDI-MedLine.d153.s1|9-17|sensitive|drug
DDI-MedLine.d153.s1|169-193|propiverine hydrochloride|drug
DDI-MedLine.d153.s1|234-260|cetirizine di-hydrochloride|drug
DDI-MedLine.d153.s1|288-290|CAS|brand
DDI-MedLine.d153.s2|103-105|C18|brand
DDI-MedLine.d153.s3|76-83|positive|drug
DDI-MedLine.d153.s4|10-20|propiverine|drug
DDI-MedLine.d153.s5|14-15|IS|brand
DDI-MedLine.d153.s6|142-167|(propiverine hydrochloride|drug
DDI-MedLine.d153.s7|48-61|quantification|group
DDI-MedLine.d153.s7|111-122|respectively|drug
DDI-MedLine.d153.s8|35-43|sensitive|drug
DDI-MedLine.d153.s8|121-135|pharmacokinetic|drug
DDI-MedLine.d153.s8|158-180|hydrochloride sustained|drug
DDI-MedLine.d219.s0|18-20|HIV|brand
DDI-MedLine.d219.s1|27-31|virus|drug
DDI-MedLine.d219.s1|39-46|epidemic|drug
DDI-MedLine.d219.s1|64-72|incidence|drug
DDI-MedLine.d219.s1|111-122|particularly|drug
DDI-MedLine.d219.s1|139-144|Africa|brand
DDI-MedLine.d219.s2|73-80|HIV/AIDS|brand
DDI-MedLine.d219.s3|48-59|HIV-infected|brand
DDI-MedLine.d219.s3|99-114|antituberculosis|group
DDI-MedLine.d219.s4|46-61|antituberculosis|group
DDI-MedLine.d219.s4|67-80|antiretroviral|group
DDI-MedLine.d219.s6|38-51|antiretroviral|group
DDI-MedLine.d219.s6|85-100|antituberculosis|group
DDI-MedLine.d219.s6|128-130|CD4|brand
DDI-DrugBank.d772.s0|10-22|Vaginal Cream|brand
DDI-DrugBank.d772.s0|33-39|TERAZOL|brand
DDI-DrugBank.d772.s0|43-63|Vaginal Suppositories|brand
DDI-DrugBank.d772.s0|71-73|The|brand
DDI-DrugBank.d772.s0|75-85|therapeutic|drug
DDI-DrugBank.d772.s0|136-148|contraceptive|drug
DDI-DrugBank.d772.s1|10-22|Vaginal Cream|brand
DDI-DrugBank.d772.s1|29-31|The|brand
DDI-DrugBank.d772.s1|114-124|terconazole|drug
DDI-DrugBank.d772.s1|217-229|contraceptive|drug
DDI-DrugBank.d593.s0|36-43|VIRAZOLE|brand
DDI-DrugBank.d593.s0|98-100|RSV|brand
DDI-DrugBank.d593.s0|122-128|digoxin|drug
DDI-DrugBank.d593.s0|131-145|bronchodilators|group
DDI-DrugBank.d593.s0|154-169|antiviral agents|group
DDI-DrugBank.d593.s0|172-182|antibiotics|group
DDI-DrugBank.d593.s0|188-203|anti-metabolites|group
DDI-DrugBank.d593.s1|16-23|VIRAZOLE|brand
DDI-DrugBank.d764.s0|116-126|anesthetics|group
DDI-DrugBank.d764.s1|68-73|agents|group
DDI-MedLine.d176.s0|7-11|oxide|drug
DDI-MedLine.d176.s1|30-37|synaptic|drug
DDI-MedLine.d176.s1|92-101|plasticity|drug
DDI-MedLine.d176.s1|209-216|synaptic|drug
DDI-MedLine.d176.s2|19-29|homeostatic|drug
DDI-MedLine.d176.s2|87-100|synaptic drive|drug
DDI-MedLine.d176.s2|107-114|evidence|drug
DDI-MedLine.d176.s3|33-40|synaptic|drug
DDI-MedLine.d176.s3|151-153|Kv3|brand
DDI-MedLine.d176.s3|158-160|Kv2|brand
DDI-MedLine.d176.s3|172-178|channel|drug_n
DDI-MedLine.d176.s3|266-277|respectively|drug
DDI-MedLine.d176.s4|12-25|oxide-mediated|drug
DDI-MedLine.d176.s4|37-48|dramatically|drug
DDI-MedLine.d176.s4|60-62|Kv2|brand
DDI-MedLine.d176.s4|147-154|synaptic|drug
DDI-MedLine.d176.s5|24-28|oxide|drug
DDI-MedLine.d176.s5|35-45|homeostatic|drug
DDI-MedLine.d176.s5|123-130|synaptic|drug
DDI-MedLine.d168.s0|24-31|synaptic|drug
DDI-MedLine.d168.s1|31-37|diverse|drug
DDI-MedLine.d168.s3|14-26|noradrenaline|drug
DDI-MedLine.d168.s5|147-157|glycinergic|drug
DDI-MedLine.d168.s6|27-33|glycine|drug
DDI-MedLine.d192.s0|20-27|dopamine|drug
DDI-MedLine.d192.s1|145-155|associative|drug
DDI-MedLine.d192.s2|4-6|BLA|brand
DDI-MedLine.d192.s2|8-27|receives innervation|drug_n
DDI-MedLine.d192.s2|34-45|dopaminergic|drug
DDI-MedLine.d192.s2|73-75|VTA|brand
DDI-MedLine.d192.s2|87-94|dopamine|drug
DDI-MedLine.d192.s2|101-102|D1|brand
DDI-MedLine.d192.s2|108-109|D2|brand
DDI-MedLine.d192.s3|74-76|NAc|brand
DDI-MedLine.d192.s3|78-85|combined|drug
DDI-MedLine.d192.s3|133-142|identified|drug
DDI-MedLine.d192.s3|193-197|DA D1|brand
DDI-MedLine.d192.s3|206-207|D2|brand
DDI-MedLine.d192.s3|238-240|BLA|brand
DDI-MedLine.d192.s4|20-31|opiate-naive|drug
DDI-MedLine.d192.s4|61-62|D1|brand
DDI-MedLine.d192.s4|73-74|D2|brand
DDI-MedLine.d192.s4|126-136|associative|drug
DDI-MedLine.d192.s5|102-103|D2|brand
DDI-MedLine.d192.s5|114-115|D1|brand
DDI-MedLine.d192.s6|155-156|D1|brand
DDI-MedLine.d192.s6|161-162|D2|brand
DDI-MedLine.d192.s7|73-75|NAc|brand
DDI-MedLine.d192.s7|122-130|BLA D1/D2|brand
DDI-MedLine.d192.s7|148-150|NAc|brand
DDI-MedLine.d192.s7|182-189|morphine|drug
DDI-MedLine.d192.s8|29-36|identify|drug
DDI-MedLine.d192.s8|99-101|BLA|brand
DDI-MedLine.d192.s8|214-215|D1|brand
DDI-MedLine.d192.s8|220-221|D2|brand
DDI-MedLine.d188.s1|71-77|article|drug
DDI-MedLine.d188.s1|105-115|alternative|drug
DDI-DrugBank.d730.s0|4-18|pharmacokinetic|drug
DDI-DrugBank.d730.s0|31-39|temazepam|drug
DDI-DrugBank.d730.s0|94-103|cimetidine|drug
DDI-DrugBank.d684.s0|45-61|PROTOPIC Ointment|brand
DDI-DrugBank.d684.s1|59-75|PROTOPIC Ointment|brand
DDI-DrugBank.d684.s1|82-93|systemically|group
DDI-DrugBank.d684.s2|47-56|inhibitors|group
DDI-DrugBank.d684.s2|75-84|widespread|group
DDI-DrugBank.d684.s3|32-43|erythromycin|drug
DDI-DrugBank.d684.s3|46-57|itraconazole|drug
DDI-DrugBank.d684.s3|60-71|ketoconazole|drug
DDI-DrugBank.d684.s3|74-84|fluconazole|drug
DDI-DrugBank.d684.s3|95-101|channel|drug_n
DDI-DrugBank.d684.s3|116-125|cimetidine|drug
DDI-MedLine.d178.s0|21-32|antiplatelet|group
DDI-MedLine.d178.s1|49-53|P2Y12|brand
DDI-MedLine.d178.s1|55-63|adenosine|drug
DDI-MedLine.d178.s2|23-34|antiplatelet|group
DDI-MedLine.d175.s0|35-44|colchicine|drug
DDI-MedLine.d175.s1|0-9|Colchicine|drug
DDI-MedLine.d175.s2|16-26|therapeutic|drug
DDI-MedLine.d175.s3|13-21|determine|drug
DDI-MedLine.d175.s3|44-53|colchicine|drug
DDI-MedLine.d175.s3|99-108|colchicine|drug
DDI-MedLine.d175.s3|164-173|colchicine|drug
DDI-MedLine.d175.s3|311-320|colchicine|drug
DDI-MedLine.d175.s4|16-27|IRB-approved|brand
DDI-MedLine.d175.s4|30-42|retrospective|drug
DDI-MedLine.d175.s4|95-104|university|drug
DDI-MedLine.d175.s5|44-62|received colchicine|drug
DDI-MedLine.d175.s5|95-101|January|brand
DDI-MedLine.d175.s5|115-122|February|brand
DDI-MedLine.d175.s6|45-54|colchicine|drug
DDI-MedLine.d175.s7|68-77|colchicine|drug
DDI-MedLine.d175.s7|124-133|colchicine|drug
DDI-MedLine.d175.s7|158-160|WHO|brand
DDI-MedLine.d175.s7|212-221|colchicine|drug
DDI-MedLine.d175.s8|77-95|received colchicine|drug
DDI-MedLine.d175.s10|24-33|colchicine|drug
DDI-MedLine.d175.s11|0-9|Colchicine|drug
DDI-MedLine.d175.s11|27-36|creatinine|drug
DDI-MedLine.d175.s12|19-26|received|drug
DDI-MedLine.d175.s13|0-9|Colchicine|drug
DDI-MedLine.d175.s14|24-33|colchicine|drug
DDI-DrugBank.d646.s0|10-30|Interactions Although|brand
DDI-DrugBank.d646.s0|236-251|pharmacokinetics|group
DDI-DrugBank.d646.s0|256-264|midazolam|drug
DDI-DrugBank.d646.s0|273-287|presystemically|group
DDI-DrugBank.d646.s0|292-303|systemically|group
DDI-DrugBank.d646.s1|88-98|presystemic|group
DDI-DrugBank.d646.s1|122-134|contraceptive|drug
DDI-MedLine.d212.s0|15-24|colchicine|drug
DDI-MedLine.d212.s1|25-34|colchicine|drug
DDI-MedLine.d212.s2|36-45|absorptive|drug
DDI-MedLine.d212.s3|50-59|colchicine|drug
DDI-MedLine.d212.s3|72-85|administrative|drug
DDI-MedLine.d212.s4|4-13|colchicine|drug
DDI-MedLine.d212.s4|76-82|Tween80|brand
DDI-MedLine.d212.s5|11-18|particle|drug
DDI-MedLine.d212.s6|18-27|colchicine|drug
DDI-MedLine.d212.s6|147-156|colchicine|drug
DDI-MedLine.d212.s7|41-50|colchicine|drug
DDI-MedLine.d212.s7|80-89|colchicine|drug
DDI-MedLine.d212.s8|29-38|colchicine|drug
DDI-MedLine.d212.s8|100-109|colchicine|drug
DDI-MedLine.d212.s8|125-132|relative|drug
DDI-MedLine.d212.s8|233-244|respectively|drug
DDI-MedLine.d212.s8|266-275|colchicine|drug
DDI-MedLine.d212.s9|58-67|colchicine|drug
DDI-MedLine.d212.s10|76-89|administrative|drug
DDI-MedLine.d212.s10|146-155|colchicine|drug
DDI-DrugBank.d692.s0|59-65|VIGAMOX|brand
DDI-DrugBank.d692.s1|31-42|moxifloxacin|drug
DDI-DrugBank.d692.s1|69-74|CYP2D6|drug
DDI-DrugBank.d692.s1|77-82|CYP2C9|drug
DDI-DrugBank.d692.s1|85-91|CYP2C19|brand
DDI-DrugBank.d692.s1|97-102|CYP1A2|brand
DDI-DrugBank.d692.s1|120-131|moxifloxacin|drug
DDI-DrugBank.d692.s1|158-173|pharmacokinetics|group
DDI-DrugBank.d729.s0|36-42|OXISTAT|brand
DDI-DrugBank.d729.s0|74-87|systematically|drug
DDI-MedLine.d228.s1|120-131|particularly|drug
DDI-MedLine.d228.s2|5-11|article|drug
DDI-MedLine.d228.s2|52-53|TB|brand
DDI-MedLine.d228.s2|69-74|active|drug
DDI-MedLine.d228.s2|76-77|TB|brand
DDI-MedLine.d228.s2|136-137|TB|brand
DDI-MedLine.d228.s3|9-10|TB|brand
DDI-MedLine.d158.s0|25-27|ABC|brand
DDI-MedLine.d158.s0|76-81|murine|drug
DDI-MedLine.d158.s0|126-132|Rho(-/-|brand
DDI-MedLine.d158.s1|44-54|synergistic|drug
DDI-MedLine.d158.s1|81-83|ABC|brand
DDI-MedLine.d158.s1|126-131|murine|drug
DDI-MedLine.d158.s1|184-190|Rho(-/-|brand
DDI-MedLine.d158.s2|11-12|P1|brand
DDI-MedLine.d158.s3|80-81|B6|brand
DDI-MedLine.d158.s3|117-119|ABC|brand
DDI-MedLine.d158.s3|131-137|Rho(-/-|brand
DDI-MedLine.d158.s3|145-152|combined|drug
DDI-MedLine.d158.s3|174-176|ABC|brand
DDI-MedLine.d158.s3|179-185|N-[N-(3|brand
DDI-MedLine.d158.s3|188-234|5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine|drug
DDI-MedLine.d158.s4|25-31|examine|drug
DDI-MedLine.d158.s4|77-78|B6|brand
DDI-MedLine.d158.s5|90-91|B6|brand
DDI-MedLine.d158.s5|97-103|Rho(-/-|brand
DDI-MedLine.d158.s6|22-32|substantial|group
DDI-MedLine.d158.s6|64-71|survived|drug
DDI-MedLine.d158.s6|125-127|ABC|brand
DDI-MedLine.d158.s6|134-135|B6|brand
DDI-MedLine.d158.s6|141-147|Rho(-/-|brand
DDI-MedLine.d158.s7|15-17|ABC|brand
DDI-MedLine.d158.s8|40-41|B6|brand
DDI-MedLine.d158.s9|88-94|Rho(-/-|brand
DDI-MedLine.d158.s9|107-114|combined|drug
DDI-MedLine.d158.s9|136-138|ABC|brand
DDI-MedLine.d158.s10|4-14|synergistic|drug
DDI-MedLine.d158.s10|41-43|ABC|brand
DDI-MedLine.d158.s10|128-134|Rho(-/-|brand
DDI-MedLine.d230.s0|11-18|neferine|drug
DDI-MedLine.d230.s0|27-42|pharmacokinetics|group
DDI-MedLine.d230.s1|36-45|derivative|drug
DDI-MedLine.d230.s1|52-64|predominantly|drug
DDI-MedLine.d230.s1|72-90|III anti-arrhythmic|group
DDI-MedLine.d230.s2|57-64|neferine|drug
DDI-MedLine.d230.s2|70-93|effective anti-pulmonary|group
DDI-MedLine.d230.s2|137-143|Nelumbo|brand
DDI-MedLine.d230.s2|154-163|Gaertner's|brand
DDI-MedLine.d230.s2|185-199|pharmacokinetic|drug
DDI-MedLine.d230.s3|13-26|Sprague-Dawley|brand
DDI-MedLine.d230.s3|47-53|divided|drug
DDI-MedLine.d230.s4|34-38|given|drug
DDI-MedLine.d230.s4|96-107|respectively|drug
DDI-MedLine.d230.s4|116-123|neferine|drug
DDI-MedLine.d230.s5|38-44|orbital|drug
DDI-MedLine.d230.s5|138-144|RP-HPLC|brand
DDI-MedLine.d230.s6|29-33|C(max|brand
DDI-MedLine.d230.s6|40-47|AUC(0-96|brand
DDI-MedLine.d230.s7|50-65|pharmacokinetics|group
DDI-MedLine.d230.s7|164-171|neferine|drug
DDI-MedLine.d230.s7|249-256|neferine|drug
DDI-MedLine.d230.s7|293-308|pharmacokinetics|group
DDI-MedLine.d230.s8|64-76|consideration|drug
DDI-MedLine.d230.s8|83-90|combined|drug
DDI-MedLine.d230.s8|97-104|neferine|drug
DDI-MedLine.d165.s0|25-34|adjunctive|drug
DDI-MedLine.d165.s0|46-61|remineralisation|drug
DDI-MedLine.d165.s1|91-100|preventive|drug
DDI-MedLine.d165.s1|126-135|preventive|drug
DDI-MedLine.d165.s2|4-9|Casein|brand
DDI-MedLine.d165.s2|11-34|phosphopeptide-amorphous|drug
DDI-MedLine.d165.s2|90-101|remineralise|drug
DDI-MedLine.d165.s2|131-139|delivered|drug
DDI-MedLine.d165.s3|37-43|deliver|drug
DDI-MedLine.d165.s4|4-16|effectiveness|drug
DDI-MedLine.d165.s4|28-38|derivatives|group
DDI-MedLine.d165.s4|54-60|CCP-ACP|brand
DDI-MedLine.d165.s5|39-44|Casein|brand
DDI-MedLine.d165.s5|46-69|phosphopeptide-amorphous|drug
DDI-MedLine.d165.s5|101-108|provides|group
DDI-MedLine.d165.s6|32-38|provide|drug
DDI-DrugBank.d660.s1|3-7|Trial|brand
DDI-DrugBank.d660.s1|59-65|Synagis|brand
DDI-DrugBank.d660.s1|81-96|received routine|drug
DDI-DrugBank.d660.s1|108-115|vaccines|group
DDI-DrugBank.d660.s1|128-134|vaccine|drug
DDI-DrugBank.d660.s1|137-151|bronchodilators|group
DDI-DrugBank.d660.s1|156-170|corticosteroids|drug
DDI-DrugBank.d660.s1|278-283|agents|group
DDI-DrugBank.d767.s1|20-38|vincristine sulfate|drug
DDI-DrugBank.d731.s0|16-27|Interactions|brand
DDI-DrugBank.d731.s0|30-34|There|brand
DDI-DrugBank.d731.s0|96-102|RITUXAN|brand
DDI-DrugBank.d673.s0|67-76|olmesartan|drug
DDI-DrugBank.d673.s0|113-119|digoxin|drug
DDI-DrugBank.d673.s0|124-131|warfarin|drug
DDI-DrugBank.d673.s1|23-32|olmesartan|drug
DDI-DrugBank.d673.s1|92-99|antacids|group
DDI-DrugBank.d673.s2|0-9|Olmesartan|drug
DDI-MedLine.d152.s1|45-54|considered|drug
DDI-MedLine.d152.s4|32-44|idiosyncratic|drug
DDI-MedLine.d152.s6|44-48|liver|drug
DDI-MedLine.d152.s7|42-59|therapeutic agents|group
DDI-MedLine.d152.s7|101-105|viral|drug
DDI-MedLine.d152.s8|47-51|liver|drug
DDI-MedLine.d152.s8|120-128|explained|drug
DDI-MedLine.d152.s9|5-19|pharmacokinetic|drug
DDI-MedLine.d152.s9|56-66|competitive|drug
DDI-MedLine.d152.s10|42-52|mechanistic|drug
DDI-MedLine.d186.s0|86-98|Brown-Sequard|brand
DDI-MedLine.d186.s4|95-103|kinematic|drug
DDI-MedLine.d186.s4|144-148|C4/C5|brand
DDI-MedLine.d186.s4|190-196|Brown-S|brand
DDI-MedLine.d186.s6|27-37|substantial|group
DDI-MedLine.d186.s6|83-90|remained|drug
DDI-MedLine.d186.s8|16-19|side|drug
DDI-MedLine.d186.s8|22-29|cortico-|drug
DDI-MedLine.d186.s8|55-68|reticulospinal|drug
DDI-MedLine.d186.s8|120-131|dopaminergic|drug
DDI-MedLine.d186.s9|50-62|monoaminergic|drug
DDI-MedLine.d186.s10|163-170|negative|drug
DDI-MedLine.d186.s10|188-197|particular|drug
DDI-MedLine.d186.s11|44-55|unresponsive|drug
DDI-MedLine.d186.s13|59-69|therapeutic|drug
DDI-MedLine.d225.s0|68-75|tinnitus|drug_n
DDI-MedLine.d225.s0|80-87|reasoned|drug
DDI-MedLine.d225.s0|101-105|guide|drug
DDI-MedLine.d225.s1|46-53|tinnitus|drug_n
DDI-MedLine.d225.s1|116-120|guide|drug
DDI-MedLine.d225.s2|29-32|side|drug
DDI-MedLine.d225.s2|82-89|tinnitus|drug_n
DDI-MedLine.d225.s2|94-102|dizziness|group
DDI-MedLine.d225.s2|208-221|pharmaceutical|drug
DDI-MedLine.d225.s3|18-25|practice|drug
DDI-MedLine.d225.s3|77-79|ENT|brand
DDI-MedLine.d225.s3|116-128|consideration|drug
DDI-MedLine.d225.s3|231-234|side|drug
DDI-MedLine.d225.s4|151-162|side-effects|drug
DDI-MedLine.d225.s5|12-17|active|drug
DDI-MedLine.d225.s5|44-53|subdivided|drug
DDI-MedLine.d225.s5|117-128|side-effects|drug
DDI-MedLine.d225.s6|93-103|therapeutic|drug
DDI-MedLine.d225.s7|33-44|alphabetical|group
DDI-MedLine.d225.s8|4-8|guide|drug
DDI-MedLine.d225.s8|35-43|conceived|drug
DDI-MedLine.d225.s8|63-67|Italy|brand
DDI-MedLine.d225.s8|201-206|active|drug
DDI-MedLine.d225.s9|4-8|guide|drug
DDI-MedLine.d205.s0|17-19|HIV|brand
DDI-MedLine.d205.s1|32-34|HIV|brand
DDI-MedLine.d205.s2|19-20|TB|brand
DDI-MedLine.d205.s2|28-39|HIV-infected|brand
DDI-MedLine.d205.s2|81-82|TB|brand
DDI-MedLine.d205.s2|147-149|HIV|brand
DDI-MedLine.d205.s3|28-41|antiretroviral|group
DDI-MedLine.d205.s3|66-68|HIV|brand
DDI-MedLine.d205.s3|155-157|ART|brand
DDI-MedLine.d205.s3|218-219|TB|brand
DDI-MedLine.d205.s4|55-57|ART|brand
DDI-MedLine.d205.s4|63-69|anti-TB|group
DDI-MedLine.d205.s4|86-97|dramatically|drug
DDI-MedLine.d205.s4|221-222|TB|brand
DDI-MedLine.d205.s5|52-54|ART|brand
DDI-MedLine.d205.s5|66-77|HIV-infected|brand
DDI-MedLine.d205.s5|113-114|TB|brand
DDI-MedLine.d205.s5|164-170|receive|drug
DDI-MedLine.d205.s5|215-218|CD4+|brand
DDI-MedLine.d205.s6|57-58|TB|brand
DDI-MedLine.d205.s6|64-66|HIV|brand
DDI-MedLine.d205.s7|103-104|TB|brand
DDI-MedLine.d205.s7|110-112|HIV|brand
DDI-DrugBank.d718.s0|14-24|Interaction|brand
DDI-DrugBank.d718.s0|41-48|Antacids|group
DDI-DrugBank.d718.s0|51-57|Calcium|brand
DDI-DrugBank.d718.s0|72-85|Cholestyramine|drug
DDI-DrugBank.d718.s0|88-94|Choline|drug
DDI-DrugBank.d718.s0|123-132|Colestipol|brand
DDI-DrugBank.d718.s0|135-149|Iron-containing|drug_n
DDI-DrugBank.d718.s0|158-166|Laxatives|group
DDI-DrugBank.d718.s0|169-177|Magnesium|brand
DDI-DrugBank.d718.s0|231-243|tetracyclines|group
DDI-DrugBank.d718.s1|5-18|contraceptives|group
DDI-DrugBank.d718.s1|41-53|tetracyclines|group
DDI-DrugBank.d718.s1|72-84|contraceptive|drug
DDI-MedLine.d196.s1|37-56|hypercholesterolemia|drug
DDI-MedLine.d196.s1|65-73|lipidemia|drug
DDI-MedLine.d196.s1|80-99|hypertriglyceridemia|drug
DDI-MedLine.d196.s2|91-96|active|drug
DDI-MedLine.d196.s3|70-80|alternative|drug
DDI-MedLine.d196.s4|86-93|relative|drug
DDI-MedLine.d196.s4|181-195|pharmacokinetic|drug
DDI-MedLine.d196.s5|58-65|received|drug
DDI-MedLine.d196.s6|87-94|received|drug
DDI-MedLine.d196.s7|78-85|received|drug
DDI-MedLine.d196.s9|4-18|pharmacokinetic|drug
DDI-MedLine.d196.s9|77-83|AUC(0-t|brand
DDI-MedLine.d196.s9|87-92|AUC(0-|brand
DDI-MedLine.d196.s9|99-103|C(max|brand
DDI-MedLine.d196.s9|111-115|T(max|brand
DDI-MedLine.d196.s10|66-67|CI|brand
DDI-MedLine.d196.s10|110-125|acid:fenofibrate|drug
DDI-MedLine.d196.s10|138-144|AUC(0-t|brand
DDI-MedLine.d196.s10|148-153|AUC(0-|brand
DDI-MedLine.d196.s10|164-169|C(max.|brand
DDI-MedLine.d196.s15|74-87|Indian/Alaskan|brand
DDI-MedLine.d196.s15|89-100|native/Asian|drug
DDI-MedLine.d196.s19|37-44|Hispanic|brand
DDI-MedLine.d196.s20|8-10|CIs|brand
DDI-MedLine.d196.s20|144-158|pharmacokinetic|drug
DDI-MedLine.d196.s20|171-175|C(max|brand
DDI-MedLine.d196.s20|179-185|AUC(0-t|brand
DDI-MedLine.d196.s20|193-198|AUC(0-|brand
DDI-MedLine.d196.s21|67-69|AEs|brand
DDI-MedLine.d196.s22|30-32|AEs|brand
DDI-MedLine.d196.s22|39-47|dizziness|group
DDI-MedLine.d196.s23|58-60|AEs|brand
DDI-MedLine.d196.s24|30-32|AEs|brand
DDI-MedLine.d196.s26|123-129|US Food|brand
DDI-MedLine.d196.s26|135-153|Drug Administration|brand
DDI-MedLine.d177.s1|86-94|incidence|drug
DDI-MedLine.d177.s2|60-68|medicines|group
DDI-MedLine.d177.s2|99-108|particular|drug
DDI-MedLine.d177.s3|156-164|incidence|drug
DDI-DrugBank.d745.s0|55-58|SAMe|brand
DDI-MedLine.d162.s1|42-51|considered|drug
DDI-MedLine.d162.s2|128-138|therapeutic|drug
DDI-MedLine.d162.s3|181-188|positive|drug
DDI-MedLine.d162.s3|258-260|IBS|brand
DDI-MedLine.d162.s4|138-140|IBS|brand
DDI-MedLine.d162.s5|139-141|IBS|brand
DDI-DrugBank.d620.s0|0-11|Pyrazinamide|drug
DDI-DrugBank.d620.s0|49-55|ACETEST|brand
DDI-DrugBank.d620.s0|64-71|KETOSTIX|brand
DDI-DrugBank.d620.s0|76-80|urine|drug
DDI-DrugBank.d691.s0|8-15|systemic|group
DDI-DrugBank.d691.s0|29-35|Valstar|brand
DDI-DrugBank.d672.s0|0-6|Digoxin|drug
DDI-DrugBank.d672.s0|9-20|Sparfloxacin|drug
DDI-DrugBank.d672.s0|43-58|pharmacokinetics|group
DDI-DrugBank.d672.s0|63-69|digoxin|drug
DDI-DrugBank.d672.s1|0-14|Methylxanthines|group
DDI-DrugBank.d672.s1|17-28|Sparfloxacin|drug
DDI-DrugBank.d672.s1|55-66|theophylline|drug
DDI-DrugBank.d672.s2|35-46|theophylline|drug
DDI-DrugBank.d672.s2|72-86|methylxanthines|group
DDI-DrugBank.d672.s2|96-103|caffeine|drug
DDI-DrugBank.d672.s3|0-7|Warfarin|drug
DDI-DrugBank.d672.s3|10-21|Sparfloxacin|drug
DDI-DrugBank.d672.s3|45-58|anti-coagulant|group
DDI-DrugBank.d672.s3|70-77|warfarin|drug
DDI-DrugBank.d672.s4|0-9|Cimetidine|drug
DDI-DrugBank.d672.s4|12-21|Cimetidine|drug
DDI-DrugBank.d672.s4|43-58|pharmacokinetics|group
DDI-DrugBank.d672.s4|63-74|sparfloxacin|drug
DDI-DrugBank.d672.s5|28-39|sparfloxacin|drug
DDI-DrugBank.d672.s5|129-140|sparfloxacin|drug
DDI-DrugBank.d672.s6|0-8|Zinc/iron|drug_n
DDI-DrugBank.d672.s6|17-26|Absorption|brand
DDI-DrugBank.d672.s6|31-40|quinolones|group
DDI-DrugBank.d672.s6|76-87|preparations|group
DDI-DrugBank.d672.s7|42-53|sparfloxacin|drug
DDI-DrugBank.d672.s8|0-9|Probenecid|drug
DDI-DrugBank.d672.s8|12-21|Probenecid|drug
DDI-DrugBank.d672.s8|42-57|pharmacokinetics|group
DDI-DrugBank.d672.s8|62-73|sparfloxacin|drug
DDI-DrugBank.d657.s0|17-26|Dronabinol|brand
DDI-DrugBank.d657.s0|30-31|In|brand
DDI-DrugBank.d657.s0|65-68|AIDS|brand
DDI-DrugBank.d657.s0|85-91|MARINOL|brand
DDI-DrugBank.d657.s0|106-113|Capsules|brand
DDI-DrugBank.d657.s0|187-192|agents|group
DDI-DrugBank.d657.s0|195-215|anti-infective agents|group
DDI-DrugBank.d657.s0|218-226|sedatives|drug_n
DDI-DrugBank.d657.s1|81-96|MARINOL Capsules|brand
DDI-DrugBank.d657.s1|99-110|cannabinoids|drug_n
DDI-DrugBank.d663.s0|54-61|LUCENTIS|brand
DDI-DrugBank.d663.s1|46-57|adjunctively|drug
DDI-DrugBank.d663.s3|45-52|LUCENTIS|brand
DDI-DrugBank.d663.s3|108-110|PDT|brand
DDI-MedLine.d207.s0|105-112|acidosis|drug
DDI-MedLine.d207.s1|95-102|acidosis|drug
DDI-MedLine.d207.s2|57-64|acidosis|drug
DDI-MedLine.d207.s2|141-148|baseline|drug
DDI-MedLine.d207.s3|40-47|diabetic|drug
DDI-MedLine.d207.s3|62-73|ketoacidosis|drug
DDI-MedLine.d207.s3|125-139|lactic acidosis|drug
DDI-MedLine.d207.s3|177-184|acidosis|drug
DDI-MedLine.d207.s5|36-45|systematic|drug
DDI-MedLine.d207.s5|165-172|acidosis|drug
DDI-DrugBank.d614.s0|49-57|PHOTOFRIN|brand
DDI-DrugBank.d614.s1|71-76|agents|group
DDI-DrugBank.d614.s1|85-97|tetracyclines|group
DDI-DrugBank.d614.s1|100-111|sulfonamides|group
DDI-DrugBank.d614.s1|114-127|phenothiazines|group
DDI-DrugBank.d614.s1|130-141|sulfonylurea|drug
DDI-DrugBank.d614.s1|156-161|agents|group
DDI-DrugBank.d614.s1|164-181|thiazide diuretics|group
DDI-DrugBank.d614.s2|13-15|PDT|brand
DDI-DrugBank.d614.s4|101-103|PDT|brand
DDI-DrugBank.d614.s6|22-27|active|drug
DDI-DrugBank.d614.s6|83-91|sufloxide|drug
DDI-DrugBank.d614.s6|127-134|mannitol|drug_n
DDI-DrugBank.d614.s6|166-168|PDT|brand
DDI-DrugBank.d614.s7|73-79|channel|drug_n
DDI-DrugBank.d614.s7|123-132|inhibitors|group
DDI-DrugBank.d614.s7|155-170|PHOTOFRIN PDT|brand
DDI-DrugBank.d614.s8|90-102|A2 inhibitors|group
DDI-DrugBank.d614.s8|136-138|PDT|brand
DDI-DrugBank.d614.s9|0-13|Glucocorticoid|drug
DDI-DrugBank.d614.s9|24-28|given|drug
DDI-DrugBank.d614.s9|57-59|PDT|brand
DDI-DrugBank.d707.s0|37-44|diuretic|group
DDI-DrugBank.d707.s0|94-99|Aredia|brand
DDI-DrugBank.d707.s1|26-31|Aredia|brand
DDI-DrugBank.d707.s2|9-29|CLINICAL PHARMACOLOGY|brand
DDI-DrugBank.d754.s0|16-32|Test Interactions|brand
DDI-DrugBank.d754.s0|35-43|Potential|brand
DDI-DrugBank.d754.s0|66-80|ERTACZOTM Cream|brand
DDI-DrugBank.d754.s0|137-150|systematically|drug
DDI-DrugBank.d644.s0|5-16|Interactions|brand
DDI-DrugBank.d644.s0|100-103|This|brand
DDI-DrugBank.d644.s0|105-112|medicine|drug
DDI-DrugBank.d644.s0|142-155|cholestyramine|drug
DDI-DrugBank.d644.s2|44-51|medicine|drug
DDI-DrugBank.d644.s2|62-82|Rifampin barbiturates|group
DDI-DrugBank.d644.s2|94-102|(Dilantin|group
DDI-DrugBank.d644.s2|105-117|carbamazepine|drug
DDI-DrugBank.d644.s2|130-138|Estrogens|brand
DDI-DrugBank.d644.s2|168-182|benzodiazepines|group
DDI-DrugBank.d644.s2|195-212|oxezepam temezepam|drug
DDI-DrugBank.d644.s3|24-32|medicines|group
DDI-DrugBank.d644.s4|94-104|antibiotics|group
DDI-DrugBank.d644.s4|106-113|warfarin|drug
DDI-MedLine.d170.s0|0-7|Positive|drug
DDI-MedLine.d170.s0|23-27|GABAA|brand
DDI-MedLine.d170.s0|72-79|chloride|drug
DDI-MedLine.d170.s0|96-105|widespread|group
DDI-MedLine.d170.s0|120-130|epilepticus|drug
DDI-MedLine.d170.s1|89-97|epileptic|drug
DDI-MedLine.d170.s2|59-68|critically|drug
DDI-MedLine.d170.s2|80-88|GABAergic|brand
DDI-MedLine.d170.s2|105-119|cation-chloride|drug
DDI-MedLine.d170.s3|75-83|epileptic|drug
DDI-MedLine.d170.s3|121-135|characteristics|group
DDI-MedLine.d170.s3|175-180|GABA(A|brand
DDI-MedLine.d170.s3|212-223|postsynaptic|drug
DDI-MedLine.d170.s3|308-318|epilepticus|drug
DDI-MedLine.d170.s3|363-372|gramicidin|drug
DDI-MedLine.d170.s4|113-121|epileptic|drug
DDI-MedLine.d170.s4|168-172|IPSCs|brand
DDI-MedLine.d170.s4|208-215|positive|drug
DDI-MedLine.d170.s4|227-228|SE|brand
DDI-MedLine.d170.s5|30-41|quantitative|group
DDI-MedLine.d170.s5|140-148|epileptic|drug
DDI-MedLine.d170.s5|199-202|Cl(-|brand
DDI-MedLine.d170.s5|255-258|KCC2|brand
DDI-MedLine.d170.s5|273-276|Cl(-|brand
DDI-MedLine.d170.s5|334-338|NKCC1|brand
DDI-MedLine.d170.s6|40-54|cation-chloride|drug
DDI-MedLine.d170.s6|101-105|NKCC1|brand
DDI-MedLine.d170.s6|180-181|SE|brand
DDI-DrugBank.d583.s0|49-63|succinylcholine|drug
DDI-DrugBank.d583.s1|108-116|temazepam|drug
DDI-DrugBank.d583.s2|46-52|esmolol|drug
DDI-DrugBank.d583.s2|70-80|neostigmine|drug
DDI-DrugBank.d583.s2|83-95|physostigmine|drug
DDI-DrugBank.d583.s2|102-110|midazolam|drug
DDI-MedLine.d174.s0|16-25|inhibitors|group
DDI-MedLine.d174.s0|31-42|antiplatelet|group
DDI-MedLine.d174.s0|76-84|selective|drug
DDI-MedLine.d174.s0|111-127|anti-inflammatory|group
DDI-MedLine.d174.s0|152-160|practice]|drug
DDI-MedLine.d174.s1|13-29|anti-inflammatory|group
DDI-MedLine.d174.s1|65-73|medicines|group
DDI-MedLine.d174.s1|84-87|wide|drug
DDI-MedLine.d174.s2|61-65|NSAID|brand
DDI-MedLine.d174.s2|124-128|NSAID|brand
DDI-MedLine.d174.s3|67-91|cyclooxygenase inhibitors|group
DDI-MedLine.d174.s3|159-162|NSAI|brand
DDI-MedLine.d151.s3|0-10|Angiotensin|drug_n
DDI-MedLine.d151.s4|64-76|antiagregants|group
DDI-MedLine.d151.s4|82-95|anticoagulants|group
DDI-MedLine.d151.s4|125-137|beta-blockade|group
DDI-MedLine.d151.s5|29-35|channel|drug_n
DDI-MedLine.d151.s5|47-55|diuretics|group
DDI-MedLine.d151.s5|61-67|digoxin|drug
DDI-MedLine.d151.s6|60-63|side|drug
DDI-MedLine.d151.s6|168-174|article|drug
DDI-DrugBank.d733.s1|95-107|anti-platelet|group
DDI-DrugBank.d733.s1|120-130|therapeutic|drug
DDI-DrugBank.d733.s2|56-63|kinetics|group
DDI-DrugBank.d733.s2|68-77|diclofenac|drug
DDI-DrugBank.d733.s2|82-90|ibuprofen|drug
DDI-MedLine.d202.s1|13-23|therapeutic|drug
DDI-MedLine.d202.s1|60-75|immunosupressive|drug
DDI-MedLine.d202.s1|149-165|immunosuppressive|drug
DDI-MedLine.d202.s1|194-201|medicine|drug
DDI-MedLine.d202.s2|69-85|immunosuppressive|drug
DDI-MedLine.d202.s2|121-132|prophylactic|drug
DDI-MedLine.d202.s3|62-71|predictors|drug
DDI-MedLine.d202.s3|131-137|genetic|drug
DDI-MedLine.d202.s3|213-221|sensitive|drug
DDI-MedLine.d202.s4|11-21|therapeutic|drug
DDI-MedLine.d202.s4|80-88|effective|drug
DDI-MedLine.d202.s5|40-51|quantitative|group
DDI-MedLine.d202.s5|134-143|multicolor|drug
DDI-MedLine.d202.s6|135-141|diverse|drug
DDI-MedLine.d202.s6|167-175|dendritic|drug
DDI-MedLine.d202.s8|58-68|synergistic|drug
DDI-MedLine.d202.s8|74-85|antagonistic|drug
DDI-MedLine.d202.s8|114-130|immunosuppressive|drug
DDI-MedLine.d202.s8|173-179|predict|drug
DDI-MedLine.d202.s9|90-100|therapeutic|drug
DDI-MedLine.d202.s9|144-160|immunosuppressive|drug
DDI-MedLine.d232.s4|98-119|receive antithrombotic|group
DDI-MedLine.d232.s4|141-149|vitamin K|group
DDI-MedLine.d232.s5|80-86|receive|drug
DDI-MedLine.d232.s6|97-105|vitamin K|group
DDI-MedLine.d232.s7|33-46|anticoagulants|group
DDI-MedLine.d232.s8|15-28|anticoagulants|group
DDI-MedLine.d232.s8|85-93|vitamin K|group
DDI-MedLine.d149.s0|0-10|[Protective|drug
DDI-MedLine.d149.s0|101-112|Abeta(1-40)]|group
DDI-MedLine.d149.s1|65-74|Abeta(1-40|group
DDI-MedLine.d149.s1|85-94|protective|drug
DDI-MedLine.d149.s2|32-41|Abeta(1-40|group
DDI-MedLine.d149.s3|26-32|Annexin|drug_n
DDI-MedLine.d149.s3|34-42|V-FITC/PI|brand
DDI-MedLine.d149.s3|61-63|MTP|brand
DDI-MedLine.d149.s3|109-115|Western|brand
DDI-MedLine.d149.s3|169-170|AP|brand
DDI-MedLine.d149.s3|206-215|determined|drug
DDI-MedLine.d149.s4|64-76|proliferative|drug
DDI-MedLine.d149.s4|88-96|apoptotic|drug
DDI-MedLine.d149.s5|4-12|apoptotic|drug
DDI-MedLine.d149.s5|90-93|L(-1|brand
DDI-MedLine.d149.s5|96-104|Abeta(-40|group
DDI-MedLine.d149.s6|15-18|L(-1|brand
DDI-MedLine.d149.s6|49-61|proliferative|drug
DDI-MedLine.d149.s7|11-14|EGGB|brand
DDI-MedLine.d149.s7|23-26|L(-1|brand
DDI-MedLine.d149.s8|0-9|Abeta(1-40|group
DDI-MedLine.d149.s9|23-37|neuroprotective|drug
DDI-MedLine.d149.s9|183-195|proliferative|drug
DDI-MedLine.d172.s0|76-85|systematic|drug
DDI-MedLine.d172.s0|155-165|Netherlands|brand
DDI-MedLine.d172.s2|123-125|DDI|brand
DDI-MedLine.d172.s3|85-92|practice|drug
DDI-MedLine.d172.s3|115-124|identified|drug
DDI-MedLine.d172.s3|173-175|DDI|brand
DDI-MedLine.d172.s4|121-124|DDIs|brand
DDI-MedLine.d172.s5|15-18|DDIs|brand
DDI-MedLine.d172.s5|105-112|practice|drug
DDI-MedLine.d172.s5|121-131|Netherlands|brand
DDI-MedLine.d172.s6|68-71|DDIs|brand
DDI-MedLine.d172.s6|189-197|Appraisal|brand
DDI-MedLine.d172.s6|217-224|Research|brand
DDI-MedLine.d172.s6|230-239|Evaluation|brand
DDI-MedLine.d172.s6|249-258|Instrument|brand
DDI-MedLine.d172.s9|4-6|DDI|brand
DDI-MedLine.d172.s10|79-86|received|drug
DDI-MedLine.d172.s12|25-37|non-directive|drug
DDI-MedLine.d172.s12|66-75|'consider'|drug
DDI-MedLine.d172.s13|14-16|DDI|brand
DDI-MedLine.d172.s13|83-98|AGREE Instrument|brand
DDI-MedLine.d172.s13|105-117|consideration|drug
DDI-MedLine.d172.s14|21-23|DDI|brand
DDI-MedLine.d172.s15|11-19|guideline|drug
DDI-MedLine.d172.s15|52-63|particularly|drug
DDI-DrugBank.d724.s0|60-67|Infergen|brand
DDI-DrugBank.d724.s1|65-70|agents|group
DDI-DrugBank.d724.s1|121-126|agents|group
DDI-DrugBank.d724.s1|171-175|P-450|brand
DDI-DrugBank.d724.s1|187-194|Patients|brand
DDI-DrugBank.d724.s1|293-303|therapeutic|drug
DDI-DrugBank.d664.s0|38-45|thinners|drug_n
DDI-DrugBank.d664.s0|60-67|warfarin|drug
DDI-DrugBank.d664.s1|11-18|warfarin|drug
DDI-DrugBank.d664.s1|67-74|warfarin|drug
DDI-DrugBank.d719.s0|0-7|Combined|drug
DDI-DrugBank.d719.s0|18-31|MAO inhibitors|group
DDI-DrugBank.d719.s0|43-49|avoided|drug
DDI-DrugBank.d621.s0|2-10|Increased|brand
DDI-DrugBank.d621.s0|27-40|anticoagulants|group
DDI-DrugBank.d621.s1|2-10|Decreased|brand
DDI-DrugBank.d621.s1|38-51|cholestyramine|drug
DDI-DrugBank.d621.s1|54-60|mineral|drug
DDI-MedLine.d155.s0|36-43|Purkinje|brand
DDI-MedLine.d155.s0|78-83|cortex|drug
DDI-MedLine.d155.s1|47-52|cortex|drug
DDI-MedLine.d155.s1|140-147|Purkinje|brand
DDI-MedLine.d155.s2|29-39|predictions|drug
DDI-MedLine.d155.s2|88-95|Purkinje|brand
DDI-MedLine.d155.s3|21-28|Purkinje|brand
DDI-MedLine.d155.s3|84-91|Purkinje|brand
DDI-MedLine.d155.s4|55-66|connectivity|drug_n
DDI-MedLine.d155.s4|125-132|Purkinje|brand
DDI-MedLine.d155.s7|39-46|Purkinje|brand
DDI-MedLine.d155.s7|53-59|provide|drug
DDI-MedLine.d155.s9|78-84|provide|drug
DDI-MedLine.d155.s9|88-97|systematic|drug
DDI-MedLine.d155.s9|125-132|Purkinje|brand
DDI-MedLine.d155.s9|205-212|Purkinje|brand
DDI-MedLine.d155.s10|88-95|Purkinje|brand
DDI-MedLine.d155.s11|82-89|examined|drug
DDI-MedLine.d155.s11|168-175|Purkinje|brand
